Andrew Lo, 10% Owner at Urovant Sciences Ltd. (UROV), bought 21,367 shares at $7.55 ($162K) on 2019-05-29, disclosed to the SEC on 2019-05-29.
Open-market purchase of $162k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.70 | 3,796 | $29K | 18.0% |
| 2 | $7.68 | 3,807 | $29K | 18.0% |
| 3 | $7.55 | 6,882 | $52K | 32.0% |
| 4 | $7.55 | 6,882 | $52K | 32.0% |
| Total | $7.60 avg | 21,367 | $162K | 100% |
| Filing → |
| BBIO | BUY | 2022-01-03 | $99K | — | Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |